Post-divestiture, IFF signals a Capex target of 5-6% of sales, with near-term leaning toward ~6% to fund high-return initiatives. Reinvestment is anchored in R&D/innovation for the Remainco, with R&D running around 8-9% of sales and potential increases as sales grow.
Generated by Dafinchi AI. Source-grounded AI analysis, not investment advice.
What did management say about Capex and reinvestment post-divestiture?
Management said IFF would target Capex in the range of 5% to 6% of sales going forward. 1 They also clarified near-term timing: management expected to be at the upper end of that 5%–6% range (closer to 6%) over the next 1–2 years because of “critical initiatives” they described as high-return and continuing on a go-forward basis. 2
Management linked reinvestment directly to innovation and competitive positioning for the remaining (“Remainco”) businesses. 1 Specifically, they emphasized that it is important to “critically continue to reinvest in this business” and described a reinvestment “circle” where investment supports better growth rates and margin expansion, which then enables ongoing reinvestment. 1
They also gave context on R&D spending as a reinvestment measure:
Management framed the post-divestiture period as a combination of (a) reinvestment/innovation and (b) execution to address remaining stranded costs, rather than a complete “pause” in capital spending. 2 In their prepared remarks, they also highlighted a shift toward scaling the remaining businesses organically and through bolt-ons after divesting Food Ingredients. 4
While there was a question explicitly asking about quantitative Capex impacts, management’s direct answers in the excerpts focused on the 5%–6% Capex target and using the upper end (~6%) in the next 1–2 years for high-return initiatives. 12
They defined an approximate cash-generation view for the Remainco businesses using a standard metric: EBITDA minus CapEx divided by sales, saying those businesses should achieve mid- to high teens on that definition. 5 They also stated that Food Ingredients would be lower on that measure, implying a mix shift toward higher overall cash flow as the remaining portfolio becomes more dominant. 5
Additionally, management acknowledged near-term cash flow pressures and separation effects (e.g., working capital headwinds), but maintained that reinvestment and transformation would continue. 65 For instance, they expected some net working capital headwinds in 2H 2026 tied to the separation/stand process, including items such as factoring-related unwinds and potential inventory/supplier prepayments. 6 Even with those headwinds, they said free cash flow for 2026 is expected to be higher than 2025 and described the working-capital headwind as “a couple of hundred million dollars.” 5
After the Food Ingredients divestiture, management communicated a Capex target of 5%–6% of sales, with Capex leaning toward ~6% in the next 1–2 years to fund high-return initiatives. 12 They also tied reinvestment (especially R&D/innovation) to the strategy for the remaining businesses, explicitly emphasizing continued reinvestment and ongoing increases in R&D as sales grow (roughly 7% to ~9% of sales recently, with potential for further increases if value is created). 13
Disclaimer: The output generated by dafinchi.ai, a Large Language Model (LLM), may contain inaccuracies or "hallucinations." Users should independently verify the accuracy of any mathematical calculations, numerical data, and associated units, as well as the credibility of any sources cited. The developers and providers of dafinchi.ai cannot be held liable for any inaccuracies or decisions made based on the LLM's output.
IFF outlines post-divestiture Capex targets of roughly 5-6% of sales, with near-term guidance near the upper end to fund high-return initiatives, while prioritizing R&D reinvestment to support the Remainco growth and margin expansion. The discussion also covers stranded costs, cash-flow framing, and near-term working-capital headwinds tied to the divestiture.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined capital allocation plan focused on a 5%-6% Capex target, with a near-term tilt toward 6%. It also emphasizes sustained R&D investment (about 8%-9% of sales, now around 9%) to drive growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF outlines a disciplined capex framework of about 5-6% of sales, with a near-term tilt toward the upper end to fund high-return initiatives. Reinvestment remains anchored in R&D at 8-9% of sales within the Remainco strategy, alongside a stranded-cost remediation plan to protect margins and lift cash flow as the company progresses toward 2027 and 2028.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, management outlines a Capex path of about 5-6% of sales, with near-term spending at ~6% to fund high-return initiatives, while reinvestment—especially in R&D—remains central to the Remainco strategy and margin expansion. They expect the remaining portfolio to generate sufficient cash flow to support this plan, despite divestiture-related working-capital headwinds.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF explains Capex targeting 5-6% of sales post-divestiture, with near-term activity closer to 6% due to high-return initiatives. The company reaffirms a Remainco strategy focused on ongoing reinvestment, especially in R&D and innovation, to sustain growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a post-divestiture capex plan of about 5%–6% of sales, with near-term movement toward the upper end due to high-return initiatives. Management ties reinvestment to an innovation loop—driving higher R&D spend (approximately 9% of sales) and stronger Remainco cash flow—while noting working-capital headwinds related to the divestiture and expecting 2026 free cash flow to exceed 2025.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined capex path of 5–6% of sales with a near-term tilt to ~6% for high-return projects, funded by a Remainco strategy that relies on 8–9% of sales for R&D. Stranded costs of about $100 million are to be phased out over 12–24 months, underpinning anticipated better cash flow.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a disciplined reinvestment plan after the divestiture, targeting capex of 5-6% of sales (around 6% near term) to fund high-return initiatives. R&D is maintained at 8-9% of sales to sustain growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a post-divestiture capital plan: CapEx remains targeted at 5–6% of sales, with management aiming near 6% in the next 1–2 years to fund high-return initiatives and ongoing innovation. The focus shifts to the Remainco businesses while roughly $100 million of stranded costs linger, with two-thirds expected to be eliminated within 12 months and the remainder in the following year.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined reinvestment path: Capex targeted at 5-6% of sales with a bias toward 6% in the near term, and R&D around 8-9% of sales. The plan pairs ongoing reinvestment with debt reduction and a significant buyback, and positions Remainco as a cash-generative engine with 2026 free cash flow to improve despite near-term margin pressures.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Following the divestiture of Food Ingredients, management frames CapEx at 5-6% of sales, with closer to 6% in the near term to fund high-return initiatives within the Remainco transformation. R&D remains a key driver, rising to about 9% of sales, and the company emphasizes strong cash generation and a disciplined reinvestment cycle designed to lift growth and margins as sales expand.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF Management projects Capex at 5%-6% of sales after the Food Ingredients divestiture, with near-term spend skewing toward the upper end due to high-return initiatives. Reinvestment is anchored in Remainco growth through R&D at 8%-9% of sales and targeted cash-flow improvements, including a mid-to-high-teens free cash flow conversion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Dafinchi